Avid Bioservices Completes Phase One of Viral Vector Facility Construction
CDMO’s Costa Mesa location can start tackling oncology and rare disease treatment
Exothera Forms AAV Manufacturing Collaboration
Partnership aims to compare reproducibility and comparability between different suspension bioreactors
MD Logistics to Open Sixth Warehouse
New Garner, NC location will be its first outside the Midwest
Walgreens Establishes Clinical Trial Business
Endeavor aims to tackle diversity obstacles surrounding this segment, while improving the patient experience
Piramal Pharma Boosts API Services
Focus on operational excellence is playing a major role in this effort, company says
SK Pharmteco to Invest $35 Million toward Site Expansion
CDMO’s Ireland campus will increase in capacity by 50% as a result
Charles River, ASC Therapeutics Further Grow Gene Therapy Collaboration
Expanded partnership revolves around hemophilia A therapeutics
BrightInsight Enhances Digital Health Platform Solution
Configurable applications address patient and healthcare-provider interfaces, and an analytics dashboard
Yourway to Construct Depot in Ireland
Will serve as a hub, as company aims for growth in the European region
REGENXBIO Opens Gene Therapy Manufacturing Center
GMP facility allows for an increase in AAV vector production
Federal Trade Commission to Examine PBM Business Practices
Dominance of a handful of integrated firms “at the center of the US pharmaceutical system,” plus their trade practices, will be reviewed
EQT Private Equity and Mubadala to Purchase Envirotainer
Transaction totals about $3 billion
Coriolis Pharma to Expand German HQ
Project is expected to grow CRDO’s capacity by over 150,000 square feet
ParkourSC Expands Digital Supply Chain Operations Platform
Platform delivers intelligent digital twins specifically designed for real-time supply chain operations across the extended enterprise
Via Partnership, Evonik and US Government Invest $220 Million toward Lipid Production Plant
Facility, with expected completion of 2025, will specialize in mRNA-based therapies
Cambrex Acquires Q1 Scientific
Deal expands CDMO’s presence in Europe
People Spotlight — May 2022
The latest people news happenings over the past month
DFE Pharma Introduces India Center of Excellence
Goal of ‘Closer to the Formulator’ is to offer a more efficient pharma production process
Piramal Pharma Advances Oral Solid Dose Capabilities
As a result of new production area, India site’s total production capacity rises from 3 to 4.5 billion doses
Catalent Commits $175 Million to Upgrading Kentucky Facility
Investment will grow manufacturing capabilities at Winchester site
LOTTE to Purchase BMS Manufacturing Facility in New York
East Syracuse site will serve as a hub for company’s US biologics CDMO business
Pfizer and BioNTech Granted EUA for Booster Dose of COVID-19 Vaccine in Young Children
Should be administered at least five months after the second dose of the two-dose primary series
Procaps Group Acquires Grupo Somar
Deal establishes company’s presence in Mexico
HPDC Launches ‘World’s First All-in-One Supply Chain Management Solution for Advanced & Personalized Therapies’
It is the first solution that allows pharma and biotech to design, set up, plan, orchestrate, and scale APT supply chains with one single system, the company reports
Bora Pharmaceuticals Acquires Eden Biologics' CDMO Assets
Will be investing up to $100 million to expand presence in Taiwan
Tower Cold Chain Opens Los Angeles Location
Company anticipating to double global network size by end of the year
Cytiva Opening a New CGT Switzerland Facility
Among functions, 80,000 square-foot space will house a 'Center of Excellence'
PCI Pharma Services to Invest $100 Million in New Hampshire Facility
Location will feature aseptic fill-finish technology
Ashfield Engage Acquires Data Solutions Provider
Deal for PROPENSITY4 grows company’s data analytics knowledge
Pfizer to Acquire Biohaven Pharmaceuticals
Pfizer to commercialize NURTEC® ODT, an innovative compound for the prevention and acute treatment of migraine
